Pfizer to market Biosimilar INFLECTRA® in US by December
Posted on19 Oct 2016
Comments0
Pfizer Inc. will begin shipment of INFLECTRA® (infliximab-dyyb)for injection, a biosimilar of REMICADE® (infliximab) to wholesalers in the United States (U.S.) in... Read More
FDA approves Inflectra biosimilar for rheumatoid arthritis, psoriasis
The FDA has approved the biosimilar Inflectra (infliximab-dyyb) for multiple indications. Infectra is a biosimilar to Remicade (infliximab), and can be prescribed... Read More